Project Grant T32HL176443
Award Date 9/1/25
Completion Date 8/31/30
Dollars Obligated $431K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Nashville, TN 37203, USA
Similar Awards
- The Project Grant award titled "IPEDIHEART: INTERDISCIPLINARY RESEARCH TRAINING PROGRAM FOR PEDIATRIC HEART DISEASE" is funded by the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) for $200,938 from September 1, 2025 to August 31, 2030. The grant supports an interdisciplinary research training program at Duke University focused on advancing scientific understanding and treatment of pediatric and congenital heart diseases. The program aims to...
- This federal Project Grant, awarded by the National Heart Lung and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research), supports research to assess the timing and risk of developing Persistent Inflammation, Immunosuppression, and Catabolism Syndrome (PICS) and sepsis in children following congenital heart defect (CHD) surgery. The $271,938 award to Vanderbilt University Medical Center (VUMC) will fund a deeper analysis of institutional databases to understand how this syndrome...
- This $373,168 Project Grant award from the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) supports the Postdoctoral Research Training in Child Health Equity program at Rhode Island Hospital, a division of Lifespan Corporation. The program aims to address persistent health inequities in pediatric conditions such as asthma, obesity, and sleep problems that disproportionately impact minoritized and socioeconomically under-resourced children. The training...
- This federal Project Grant award of $159,624.00 from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) supports research at Vanderbilt University Medical Center (VUMC) to investigate the role of hypoxia-inducible factor (HIF) in promoting alveolar regeneration and functional lung repair for patients with idiopathic pulmonary fibrosis (IPF) and other chronic lung diseases. The research aims to explore how modulating upstream disease mechanisms,...
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a $180,174 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to The Children's Hospital of Philadelphia Research Institute. The grant will fund a study to develop a framework for designing the next generation of pediatric acute respiratory distress syndrome (ARDS) clinical trials. Key objectives include: 1) Comparing heterogeneity of treatment effect (HTE) analysis methodologies in a trial of pediatric...
- This $153,117 federal Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) supports the development of the recipient's independent research career as an academic hematopathology physician-scientist. The key objectives are to study hematopoietic stem and progenitor cell (HSPC) crosstalk and transplantation, with the overarching goal of improving HSPC transplantation outcomes. The award period runs from August 1, 2025 to July 31,...
- This $502,536 federal Project Grant awarded on January 1, 2025 by the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) supports a research training program in pediatric classical hematology at St. Jude Children's Research Hospital Inc. The program will provide enriched training for three postdoctoral fellows to conduct hypothesis-driven research aimed at elucidating the mechanisms of non-malignant blood disorders and identifying new therapeutic...
- The federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides funding of $158,544 to Vanderbilt University Medical Center (VUMC) from August 1, 2025 to July 31, 2030. The project aims to advance the understanding of clonal hematopoiesis of indeterminate potential (CHIP) and its role in the development of atherosclerotic cardiovascular disease (ASCVD). Specifically, the grant will (1) identify...
- This $201,426 federal Project Grant awarded by the National Heart, Lung, and Blood Institute under the Cardiovascular Diseases Research program (CFDA 93.837) supports a 5-year training program in patient-oriented research in cardiovascular endocrinology at Brigham & Women's Hospital Inc. The program aims to address an impending manpower crisis in patient-oriented research by providing comprehensive, curriculum-based training and mentored research projects for motivated trainees committed...
- This Project Grant award from the National Heart, Lung, and Blood Institute, under the Cardiovascular Diseases Research federal grant program (CFDA 93.837), provides $131,571 to Vanderbilt University Medical Center to research methods for improving the trafficking of the KV11.1 potassium channel protein to treat Long QT Syndrome. The project aims to 1) test the drug candidate evacetrapib for its ability to enhance trafficking of KV11.1 variants, and 2) identify protein interactions that could...